Bailard’s Phibro Animal Health PAHC Stock Holding History

Bailard’s Portfolio PAHC Stock Details PAHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-5,300	Closed	-$293K	–	832
2026 Q1	$293K	Buy	+5,300	New	+$252K	0.01%	607
2025 Q3	–	Sell	-10,135	Closed	-$259K	–	855
2025 Q2	$259K	Buy	+10,135	New	+$221K	0.01%	655

Other funds holding PAHC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Bailard's PAHC Position: Q2 2026 in Review

Bailard sold out of Phibro Animal Health (PAHC) in Q2 2026, closing a stake of 5,300 shares — an estimated $293K sold.

Bailard first reported a position in PAHC in Q2 2025 and held it in 2 quarters. The position peaked at $293K in Q1 2026. 208 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

Bailard reported no remaining Phibro Animal Health position as of Q2 2026 after selling out during the quarter.
Bailard sold 5,300 Phibro Animal Health shares in Q2 2026, an estimated $293K.
Bailard first reported a position in Phibro Animal Health in Q2 2025 and held it in 2 quarters.
Bailard's Phibro Animal Health position peaked at $293K in Q1 2026.
208 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on Bailard's 13F filing for Q2 2026, filed 30 Jul 2026.